Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 10
Original Research
A combination of p53-activating APR-246 and phosphatidylserine-targeting antibody potently inhibits tumor development in hormone-dependent mutant p53-expressing breast cancer xenografts
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,205 | Dovepress* | 10,307+ | 1,397 | 11,704 | |
| PubMed Central* | 898 | 205 | 1,103 | ||
| Totals | 11,205 | 1,602 | 12,807 | ||
| *Since 22 March 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 38 | 1 | 0 | 0 | 6 | 31 |
View citations on PubMed Central and Google Scholar